EGFR and diabetic retinopathy: In this regard, a recent study provided strong evidence that EGFR promoted retinal vascular abnormalities, retinal dysfunction, and retinal structural impairment caused by diabetic retinopathy in mice, and the use of an EGFR inhibitor suppresses inflammation and possesses potential therapeutic targets for treating diabetic retinopathy [41].